Evidence map›Paper›PMID 37779073›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Successful Pregnancy Outcome in a Patient with Juvenile Idiopathic Arthritis in Adulthood, Amyloid A Amyloidosis, and Chronic Kidney Disease Using Tocilizumab with Strict Blood Pressure Control.

Taro Akira, Yukiko Shimazu, Nobuhiro Hashimoto, Hiroki Okushima, Takehiro Suzuki, Tomomi Tada, Makiko Ikoma, Takashi Hosokawa, Yoshiyasu Ueda, Masahiko Takemura and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Taro AkiraDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Yukiko ShimazuDepartment of Obstetrics/Gynecology, Osaka General Medical Center, Japan.
Nobuhiro HashimotoDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Japan.
Hiroki OkushimaDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Japan.
Takehiro SuzukiDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Tomomi TadaDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Makiko IkomaDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Takashi HosokawaDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Yoshiyasu UedaDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Japan.
Masahiko TakemuraDepartment of Obstetrics/Gynecology, Osaka General Medical Center, Japan.
Hiroshi FujiwaraDivision of Rheumatology and Allergy, Osaka General Medical Center, Japan.
Osaka Prefectural Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancies with chronic kidney disease (CKD) and high disease activity in rheumatic diseases are high-risk events with adverse outcomes for both the mother and fetus. We herein report a 35-year-old woman with juvenile idiopathic arthritis (JIA), amyloid A (AA) amyloidosis related to JIA, and CKD stage G4A2 who wished to have children. She achieved a successful pregnancy, even in the presence of these multiple risk factors, using tocilizumab to control the disease activity of JIA and AA amyloidosis, along with antihypertensive drugs to control her blood pressure before and during pregnancy.

Indexed as

AmyloidosisAntibodies, Monoclonal, HumanizedArthritis, JuvenileRenal Insufficiency, ChronicAdultAntihypertensive AgentsBlood PressureFemaleHumansPregnancyPregnancy ComplicationsPregnancy OutcomeSerum Amyloid A ProteinAntibodies, Monoclonal, HumanizedAntihypertensive AgentsSerum Amyloid A Proteintocilizumabamyloid A amyloidosischronic kidney diseaseJuvenile idiopathic arthritispregnancyrheumatic diseasestocilizumab

Identifiers

PMID37779073
PMCPMC11116017
OpenAlexW4387123508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.